Effects of tunicamycin on protein glycosylation and development inVolvox carteri

Nurith Kurn1, Dan Duksin1

  • 1Department of Biophysics, The Weizmann Institute of Science, Rehovot, Israel.

Insights

Protein glycosylation is crucial for Volvox carteri development. Inhibiting this process with tunicamycin disrupts reproductive cell maturation, cellular organization, and progeny release, highlighting its regulatory role.

Area of Science:

  • * Molecular Biology
  • * Developmental Biology
  • * Biochemistry

Background:

  • * Protein glycosylation plays a vital role in cellular processes across eukaryotes.
  • * The multicellular green alga Volvox carteri exhibits complex developmental patterns.
  • * Understanding glycosylation's impact on Volvox development can provide insights into conserved biological mechanisms.

Purpose of the Study:

  • * To investigate the role of protein glycosylation in regulating Volvox carteri development.
  • * To identify specific developmental processes affected by the inhibition of glycosylation.
  • * To elucidate the molecular changes associated with disrupted glycosylation in Volvox.

Main Methods:

  • * Treatment of Volvox carteri with the antibiotic tunicamycin, an inhibitor of protein glycosylation.
  • * Biochemical assays to assess tunicamycin's effect on key glycosylation enzymes.
  • * Metabolic labeling of proteins with radioactive amino acids and sugars.
  • * Electrophoresis (SDS-PAGE) to analyze changes in glycoprotein structure and levels.
  • * Lectin binding assays (Concanavalin A) to evaluate surface glycoprotein alterations.

Main Results:

  • * Tunicamycin treatment significantly affected reproductive cell maturation, embryogenesis, and progeny release in Volvox.
  • * The antibiotic inhibited the enzymatic transfer of GlcNAc-1-phosphate to dolichyl phosphate.
  • * Alterations in the glycosylation patterns of cellular and secreted glycoproteins were observed.
  • * Tunicamycin treatment led to reduced levels of some secreted proteins and the appearance of a novel protein band.
  • * Changes in the electrophoretic mobility of surface macromolecules and reduced Concanavalin A binding were noted.

Conclusions:

  • * Inhibition of protein glycosylation by tunicamycin leads to aberrant development in Volvox carteri.
  • * The observed developmental defects are likely due to alterations in the structure of cellular, secreted, and surface glycoproteins.
  • * Protein glycosylation is a critical regulatory mechanism for key developmental processes in Volvox.

Related Concept Videos